Riti Shimkhada, PhD

home / authors / riti-shimkhada-phd

Articles

April 21st 2015

Managing Specialty Care in an Era of Heightened Accountability: Emphasizing Quality and Accelerating Savings

John W. Peabody, MD, PhD, DTM&H Xiaoyan Huang, MD Riti Shimkhada, PhD Meredith Rosenthal, PhD

The authors report on a conceptual "specialty ACO" design in cardiology in which cardiology-specific historic spending targets are created to capture cardiovascular disease—related reimbursement and a quality measurement system is introduced.

September 17th 2014

New Thinking on Clinical Utility: Hard Lessons for Molecular Diagnostics

John W. Peabody, MD, PhD, DTM&H, FACP Riti Shimkhada, PhD Kuo B. Tong, MS Matthew B. Zubiller, MBA

The authors describe 5 basic requirements for planning, implementing, and proving clinical utility for diagnostic tests, drawing on recent reimbursement decisions.

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Entresto packaging | Image credit: Novartis

Published: November 18th 2024 | Updated: November 20th 2024

Cardiomyopathy Risk Plummets When Sacubitril/Valsartan Taken With Chemo

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions